background
angiotensinconvert
enzym
homologu
angiotensinconvert
enzym
ace
produc
angiotensin
peptid
ap
angiotensin
vasodilatori
natriuret
act
counterbal
angiotensin
ii
hypothesi
evid
found
tissu
plasma
dog
equilibrium
concentr
renin
angiotensin
aldosteron
system
raa
ap
differ
dog
heart
diseas
compar
healthi
dog
recombin
human
alter
rel
concentr
ap
anim
fortynin
dog
dog
without
heart
diseas
method
immunohistochemistri
assay
tissu
plasma
activ
equilibrium
concentr
plasma
raa
ap
perform
result
immunolabel
present
kidney
myocardi
tissu
median
plasma
activ
significantli
increas
dog
congest
heart
failur
chf
mumg
interquartil
rang
iqr
compar
control
mumg
iqr
p
plasma
equilibrium
analysi
raa
ap
identifi
signific
increas
median
concentr
benefici
ap
abbrevi
ace
angiotensinconvert
enzym
angiotensinconvert
enzym
acei
angiotensinconvert
enzym
inhibitor
ace
surr
surrog
measur
ace
activ
amp
aminopeptidas
angiotensin
angiotensin
angiotensin
angiotensin
angiotensin
angiotensin
ap
angiotensin
peptid
angiotensin
angiotensin
ii
angiotensin
iii
angiotensin
iv
chf
congest
heart
failur
dcm
dilat
cardiomyopathi
dmvd
degen
mitral
valv
diseas
ihc
immunohistochemistri
la
ao
left
atrium
aortic
root
diamet
ratio
lviddn
normal
left
ventricular
intern
diamet
enddiastol
lvidsn
normal
left
ventricular
intern
diamet
endsystol
mca
pra
surr
surrog
measur
plasma
renin
activ
raa
reninangiotensinaldosteron
system
recombin
human
angiotensinconvert
enzym
rt
room
temperatur
larouchelebel
kerri
loughran
contribut
equal
studi
reninangiotensinaldosteron
system
raa
play
import
role
pathophysiolog
heart
diseas
heart
failur
dog
tradit
concept
raa
follow
cardiac
diseas
well
treatment
cardiac
diseas
diuret
decreas
perfus
kidney
activ
releas
renin
convert
angiotensinogen
acid
peptid
angiotensin
subsequ
dipeptidylcarboxypeptidas
angiotensinconvert
enzym
ace
cleav
amino
acid
cterminu
form
octapeptid
angiotensin
ii
angiotensin
ii
act
primarili
angiotensin
receptor
type
caus
potent
vasoconstrict
sodium
water
conserv
aldosteron
releas
myocardi
remodel
thu
tradit
view
raa
linear
maladapt
patholog
system
overact
heart
failur
often
suppress
use
ace
inhibitor
acei
aldosteron
antagonist
understand
chang
discoveri
homologu
ace
call
angiotensinconvert
enzym
like
ace
membranebound
zinc
metalloproteinas
catalyt
site
capabl
bind
variou
angiotensin
peptid
ap
howev
monocarboxypeptidas
remov
singl
amino
acid
cterminu
catalyt
substrat
exampl
act
produc
acid
peptid
call
angiotensin
acid
peptid
call
angiotensin
respect
despit
differ
amino
acid
biolog
effect
opposit
associ
specif
vasodilatori
natriuret
diuret
antifibrot
antiremodel
benefici
ap
mediat
major
effect
bind
angiotensin
receptor
type
endogen
orphan
ma
receptor
masr
oppos
bind
known
system
provid
endogen
counterbal
ace
expand
view
raa
involv
mani
differ
ap
structur
differ
amino
acid
thu
raa
consider
complex
tradit
view
discoveri
uncov
broad
new
set
molecul
explor
understand
potenti
modifi
subject
heart
diseas
littl
known
system
relat
ap
veterinari
speci
best
knowledg
studi
dog
natur
occur
heart
diseas
lack
sought
detect
describ
locat
immunoreact
kidney
left
ventricular
lv
myocardium
quantifi
activ
plasma
kidney
lv
myocardi
determin
equilibrium
concentr
differ
circul
ap
determin
effect
recombin
human
rel
amount
benefici
versu
maladapt
ap
hypothes
evid
could
found
tissu
plasma
dog
equilibrium
concentr
raa
ap
would
differ
dog
heart
diseas
versu
healthi
dog
recombin
human
alter
rel
concentr
ap
studi
protocol
review
approv
univers
pennsylvania
institut
anim
care
use
committe
inform
owner
consent
obtain
cohort
dog
die
euthan
cardiac
diseas
dog
die
noncardiac
reason
univers
pennsylvania
recruit
section
left
kidney
includ
cortic
medullari
tissu
full
thick
lv
myocardi
sampl
later
wall
ventricl
apic
midpoint
paracon
coronari
arteri
obtain
within
minut
death
kidney
myocardi
sampl
fix
neutral
buffer
formalin
hour
follow
section
rabbit
polyclon
primari
antibodi
aviva
system
biolog
san
diego
california
use
dilut
incub
section
minut
room
temperatur
rt
biotinfre
polymer
ihc
detect
system
consist
horseradish
peroxidas
conjug
antirabbit
igg
appli
minut
rt
final
slide
counterstain
hematoxylin
scan
leica
aperio
versa
slide
scanner
leica
biosystem
buffalo
grove
illinoi
imag
acquir
imagescop
leica
biosystem
buffalo
grove
illinoi
addit
detail
regard
ihc
method
found
support
inform
cohort
dog
year
age
activ
previou
congest
heart
failur
chf
caus
degen
mitral
valv
diseas
dmvd
prospect
recruit
criteria
dmvd
includ
left
apic
systol
murmur
echocardiograph
evid
thicken
prolaps
mitral
valv
leaflet
mitral
regurgit
echocardiograph
examin
philip
healthcar
andov
massachusett
record
left
ventricular
intern
dimens
end
diastol
lviddn
endsystol
lvidsn
right
short
axi
view
normal
bodi
weight
use
previous
report
formula
left
atriumtoaort
root
ratio
la
ao
calcul
use
measur
right
short
axi
echocardiograph
valu
averag
valu
measur
beat
healthi
dog
primarili
own
staff
employe
veterinari
hospit
recruit
control
group
includ
dog
without
heart
murmur
clinic
sign
suggest
heart
diseas
control
dog
weigh
kg
echocardiogram
perform
exclud
potenti
occult
dilat
cardiomyopathi
dcm
venipunctur
perform
lithium
heparin
plasma
sampl
obtain
sampl
store
c
batch
analysi
activ
heparin
plasma
measur
use
fluorometr
assay
kit
biovis
inc
milpita
california
activ
result
report
milliunit
per
mg
protein
mumg
assay
lower
detect
limit
mu
addit
detail
regard
perform
valid
assay
describ
support
inform
cohort
dog
die
euthan
consequ
cardiac
diseas
dog
die
noncardiac
diseas
recruit
obtain
kidney
lv
myocardi
sampl
previous
describ
kidney
lv
myocardium
lysat
prepar
homogen
approxim
tissu
section
lysi
buffer
biovis
inc
use
dispos
tissu
homogen
fisher
thermo
scientif
waltham
massachusett
lysat
kept
ice
minut
follow
gentl
vortex
follow
anoth
minut
ice
tissu
lysat
centrifug
c
minut
pellet
discard
activ
tissu
lysat
measur
use
fluorometr
assay
kit
use
assay
plasma
activ
protein
concentr
plasma
tissu
lysat
measur
use
bicinchonin
acid
method
bovin
serum
albumin
protein
standard
biovis
inc
cohort
dog
year
age
dmvd
dcm
either
preclin
ie
asymptomat
chf
recruit
criteria
diagnosi
dmvd
dog
recruit
studi
plasma
activ
assay
criteria
diagnosi
dcm
presenc
systol
dysfunct
lv
eccentr
hypertrophi
echocardiographi
defin
lvidsn
lviddn
normal
refer
rang
absenc
identifi
cardiac
caus
previous
report
clinic
stage
system
dog
dmvd
mod
descript
statist
variou
patient
group
gener
normal
test
use
shapirowilk
test
nonparametr
test
use
data
normal
distribut
data
lower
limit
quantif
particular
assay
enter
valu
equal
time
lower
limit
quantif
previous
recommend
presenc
extrem
outli
data
point
identifi
grubb
test
restrict
potenti
remov
data
point
data
set
differ
unpair
group
test
use
wilcoxon
rank
sum
unpair
test
differ
across
group
test
use
kruskalw
analysi
varianc
anova
post
hoc
pairwis
comparison
perform
use
dunn
test
correct
multipl
comparison
bonferroni
correct
respect
box
whisker
plot
construct
line
repres
median
valu
limit
box
repres
percentil
whisker
extend
percentil
correl
among
variou
patient
demograph
data
echocardiograph
variabl
assay
result
explor
use
pearson
correl
coeffici
spearman
rho
unadjust
p
valu
concentr
ap
administr
evalu
wilcoxon
sign
rank
test
data
shown
median
interquartil
rang
unless
otherwis
specifi
statist
procedur
perform
use
statist
softwar
prism
os
x
graphpad
softwar
inc
la
jolla
california
signific
defin
p
figur
result
consist
regardless
whether
outlier
valu
includ
analysi
signific
correl
found
activ
age
r
p
bodi
weight
spearman
r
p
healthi
cohort
figur
result
regardless
whether
outlier
valu
includ
analysi
activ
per
milligram
protein
kidney
tissu
approxim
time
higher
circul
lv
myocardi
activ
assay
circul
tissu
activ
perform
averag
day
rang
date
sampl
collect
b
l
e
signal
exist
treatment
dog
undergo
assess
plasma
angiotensinconvert
enzym
activ
includ
healthi
dog
dog
congest
heart
failur
chf
degen
mitral
valv
diseas
data
shown
count
median
interquartil
rang
healthi
chf
p
n
sex
fm
age
year
bodi
weight
kg
tabl
differ
concentr
across
group
detect
number
ap
includ
tabl
gener
concentr
ap
highest
dog
stage
c
intermedi
stage
lowest
healthi
dog
figur
global
overview
expand
raa
identifi
larg
differ
overal
activ
rel
amount
ap
across
patient
group
figur
note
median
time
higher
stage
c
healthi
stage
dog
respect
median
stage
c
time
higher
healthi
stage
dog
respect
median
stage
c
time
higher
healthi
stage
dog
differ
across
group
found
tabl
median
ace
surr
also
significantli
differ
across
patient
group
figur
median
ace
surr
stage
c
time
lower
healthi
dog
dog
stage
tabl
discoveri
relat
ap
figur
subject
intens
studi
human
heart
diseas
knowledg
studi
first
provid
expand
view
raa
dog
heart
diseas
result
identifi
immunolabel
activ
canin
lv
myocardium
previou
report
rat
human
indic
similar
find
suggest
import
role
cardiac
function
strong
immunolabel
high
degre
activ
also
found
renal
tubular
epithelium
consist
previou
studi
dog
mice
human
result
indic
system
regul
differ
dog
heart
diseas
compar
healthi
dog
first
plasma
activ
significantli
increas
dog
chf
similar
previou
report
human
patient
heart
diseas
studi
serum
activ
significantli
increas
secondari
ischem
nonischem
heart
diseas
independ
medic
comorbid
studi
serum
activ
posit
correl
echocardiograph
heart
size
neg
correl
heart
function
independ
associ
import
clinic
event
includ
death
hospit
role
circul
solubl
oppos
tissuebound
fulli
understood
previous
mention
integr
membranebound
protein
balanc
tissu
versu
circul
mediat
membran
metalloproteinas
cleav
portion
cell
membran
releas
surround
extracellular
space
result
ectosom
contain
well
immedi
surround
extracellular
environ
enter
circul
urin
process
describ
ectodomain
shed
previou
studi
indic
shed
frequent
shed
ace
also
highli
membran
bound
tumor
necrosi
factor
interleukin
disintegrin
metalloproteas
potent
stimuli
shed
mice
human
thu
increas
circul
might
repres
patholog
displac
normal
tissu
membran
locat
mediat
part
feedback
loop
variou
substanc
decreas
activ
neg
regul
result
circul
remov
normal
locat
ideal
environ
hypothes
repres
wast
ineffect
studi
activ
circul
normal
protein
amount
approxim
less
activ
kidney
support
hypothesi
result
howev
also
indic
kidney
lv
activ
significantli
differ
dog
chf
compar
healthi
dog
suggest
shed
import
factor
total
extent
tissuebound
activ
loss
tissu
circul
would
tend
decreas
overal
compensatori
potenti
elucid
seemingli
complex
relationship
circul
tissu
need
second
import
find
studi
relationship
rel
concentr
variou
ap
within
expand
raa
provid
insight
pathophysiolog
diseas
begin
first
portion
raa
figur
result
indic
heart
diseas
dog
associ
increas
plasma
renin
activ
find
consist
previou
report
dog
lead
higher
concentr
stage
downstream
activ
raa
gener
b
l
e
signal
echocardiograph
treatment
data
dog
undergo
analysi
equilibrium
concentr
renin
angiotensin
aldosteron
system
angiotensin
peptid
data
shown
mean
sd
median
interquartil
rang
unless
otherwis
specifi
see
text
descript
modifi
clinic
stage
system
respect
action
ap
particular
studi
varieti
speci
includ
human
dog
rat
includ
vasodilat
natriuresi
activ
nitric
oxid
antagon
b
l
e
median
interquartil
valu
plasma
equilibrium
concentr
angiotensin
peptid
surrog
measur
plasma
renin
activ
prasurrog
angiotensinconvert
enzym
acesurrog
activ
healthi
dog
dog
heart
diseas
see
text
descript
modifi
clinic
stage
system
angiotensin
convert
enzym
ace
activ
ace
surr
healthi
control
ctl
dog
stage
c
heart
diseas
see
text
descript
modifi
clinic
stage
system
p
p
p
p
insight
pathophysiolog
diseas
suggest
novel
treatment
approach
discuss
third
import
find
studi
abil
shift
balanc
ap
within
raa
use
determin
increas
activ
associ
poor
outcom
studi
involv
patient
intens
treatment
acut
chf
